M
Mary Pipkin
Researcher at University of Virginia
Publications - 7
Citations - 690
Mary Pipkin is an academic researcher from University of Virginia. The author has contributed to research in topics: Home hemodialysis & Hemodialysis. The author has an hindex of 6, co-authored 7 publications receiving 647 citations. Previous affiliations of Mary Pipkin include University of Iowa.
Papers
More filters
Journal ArticleDOI
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial
Michael V. Rocco,Robert S. Lockridge,Gerald J. Beck,Paul W. Eggers,Jennifer J. Gassman,Tom Greene,Brett Larive,Christopher T. Chan,Glenn M. Chertow,Glenn M. Chertow,Michael Copland,Christopher D. Hoy,Robert M. Lindsay,Nathan W. Levin,Daniel B. Ornt,Andreas Pierratos,Mary Pipkin,Sanjay Rajagopalan,John B. Stokes,Mark Unruh,Robert A. Star,Alan S. Kliger +21 more
TL;DR: Patients in the nocturnal arm had improved control of hyperphosphatemia and hypertension, but no significant benefit among the other main secondary outcomes.
Journal ArticleDOI
Recruitment and Training for Home Hemodialysis: Experience and Lessons from the Nocturnal Dialysis Trial
Mary Pipkin,Paul W. Eggers,Brett Larive,Michael V. Rocco,John B. Stokes,Rita S. Suri,Robert S. Lockridge +6 more
TL;DR: Lack of patient or family motivation and fear of the dialysis process are surmountable barriers for accepting home hemodialysis as a modality for renal replacement therapy.
Journal ArticleDOI
Nightly home hemodialysis: five and one-half years of experience in Lynchburg, Virginia.
Robert S. Lockridge,Maureen Spencer,Viola Craft,Mary Pipkin,Dolores Campbell,Lesley McPhatter,Jeanette Albert,Helen Anderson,Floyd M. Jennings,Terry Barger +9 more
TL;DR: There have been 24,239 treatments at home with a total of 84.86 patient‐years on NHHD, the longest patient for 66.7 months and the shortest for 1 month.
Journal ArticleDOI
Nocturnal Home Hemodialysis in North America
Robert S. Lockridge,Maureen Spencer,Viola Craft,Mary Pipkin,Dolores Campbell,Lesley McPhatter,Jeanette Albert,Helen Anderson,Floyd M. Jennings,Terry Barger +9 more
TL;DR: All programs performing NHD have validated Pierratos' reported results, showing improvement in quality of life, better blood pressure control with fewer medications, reduced Epogen usage, reduced hospitalizations, control of phosphorous without binders, and a greater sense of hope for patients.
Journal ArticleDOI
Six years of experience with nightly home hemodialysis access.
TL;DR: Lynchburg Nephrology Dialysis Incorporated started its nightly home hemodialysis program in September 1997 and has provided dialysis treatment to more than 2,000 patients in the past 18 months.